Loading clinical trials...

A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingPhase 1NCT05022849

A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants

The purpose of this study is to determine recommended Phase 2 dose (RP2D) regimen(s) of JNJ-75229414 in Part 1 (Dose Escalation and to determine safety at the RP2D regimen(s) in Part 2 (Dose Expansion...

Lead sponsor: Janssen Research & Development, LLC•8 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1/2

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

NCT06190899 · mCRPC (Metastatic Castration-resistant Prostate Cancer), Genital Diseases, Male, and more

RECRUITINGPhase 3

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT07225946 · Prostatic Neoplasms, Castration-Resistant

RECRUITINGNA

Prostate Adaptive Radiation Therapy

NCT06547398 · Prostatic Neoplasms

RECRUITINGPhase 1/2

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

NCT04868604 · Prostatic Neoplasms, Castration-Resistant

RECRUITINGPhase 1

A Study of DM002 in Patients With Advanced Solid Tumors

NCT06751329 · Ovarian Neoplasms, Prostatic Neoplasms, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 13, 2026Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhasePHASE1

Enrollment15

Start dateSep 2021

Last updatedMar 13, 2026

Condition

Prostatic Neoplasms

Locations shown

City of Hope Cancer Center

Duarte, California

Norton Cancer Institute

Louisville, Kentucky

University Of Minnesota

Minneapolis, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 13, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions